Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis

General Physiology and Biophysics

Volumn 28, Issue SPECIAL ISSUES, 2009, Pages 184-189

  Rasic Milutinovic, Zorica ^a   Peruničić Peković, Gordana ^a   Ristić Medić, Danijela ^b   Popović, Tamara ^b   Glibetić, Maria ^b   Djurić, Dragan M ^c  

^a Clinical Hospital Center Zemun   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Chronic inflammation; End stage renal disease; Insulin resistance; Muscle wasting

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; GLUCOSE; INSULIN; INTERLEUKIN 6; PARATHYROID HORMONE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY FAT DISTRIBUTION; BODY WATER; BODY WEIGHT; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FAILURE; LEAN BODY WEIGHT; MALE; MUSCLE ATROPHY; NUTRITIONAL STATUS; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCULAR ATROPHY; RENAL DIALYSIS;

EID: 77649258323     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chaldakov G. N., Stankulov I. S., Hristova M., Ghenev P. I. (2003): Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr. Pharm. Des. 9, 1023-1031
2. Chevalier S., Marliss B. E., Morais J. A., Lamarche M., Gougeon R. (2005): Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am. J. Clin. Nutr. 82, 355-365
3. Chow L. S., Albright R. C., Bigelow M. L., Toffolo G., Cobelli C., Nair K. S. (2006): Mechanism of insulin's anabolic effect on muscle - measurements of muscle protein synthesis and breakdown using aminoacyl tRNA and other surrogate measures. Am. J. Physiol., Endocrinol. Metab. 291, E729-736
4. Du J., Mitch W. E. (2005): Identification of pathways controlling muscle protein metabolism in uremia and other catabolic conditions. Curr. Opin. Nephrol. Hypertens. 14, 378-382
5. Felig P., Wahren J., Sherwin R., Palaiologos G. (1977): Amino acid and protein metabolism in diabetes mellitus. Arch. Intern. Med. 137, 507-513
6. Garcia-Martinez C., Lopez-Soriano F. J., Argiles J. M. (1993): Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol. Cell. Biochem. 125, 11-18
7. Gelfand R. A., Barrett E. J. (1987): Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 80, 1-6
8. Guilherme A., Virbasius J. V., Puri V., Czech M. P. (2008): Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377
9. Ikizler T. A., Flakoll P. J., Parker R. A., Hakim R. M. (1994): Amino acid and albumin losses during hemodialysis. Kidney Int. 46, 830-837
10. Kalantar-Zadeh K., Kopple J. D., Humphreys M. H., Block G. (2004): Comparingoutcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol. Dial. Transplant. 19, 1507-1519
11. Kato A., Odamaki M., Yamamoto T., Yonemura K., Maruyama Y., Kumagai H., Hishida A. (2003): Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol. Dial. Transplant. 18, 333-340
12. Lee S. W., Park G. H., Lee S. W., Song J. H., Hong K. C., Kim M. J. (2007): Insulin resistance and muscle wasting in nondiabetic end-stage renal disease patients. Nephrol. Dial. Transplant. 22, 2554-2562
13. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. (1985): Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
14. Mayer-Davis E. J., D'Agostino R. J., Karter A., Haffner S. M., Rewers M. J., Saad M., Bergman R. N. (1998): Intensity and amount of physical activity in relation to insulin sensitivity: the insulin resistance atherosclerosis study. JAMA 279, 669-674
15. Pacy P. J., Bannister P. A., Halliday D. (1991): Influence of insulin on leucine kinetics in the whole body and across the forearm in post-absorptive insulin dependent diabetic (type 1) patients. Diabetes Res. 18, 155-162
16. Pupim L. B., Heimburger O., Qureshi A. R., Ikizler T. A., Stenvinkel P. (2005): Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 68, 2368-2374
17. Rajan V. R., Mitch W. E. (2008): Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr. Nephrol. 23, 527-535
18. Rašić-Milutinović Z., Peruničić G., Plješa S. (2000): Clinical significance and pathogenetic mechanisms of insulin resistance in chronic renal insufficiency (part two): pathogenetic factors of insulin resistance in chronic renal insufficiency. Med. Pregl. 53, 159-163 (in Serbian)
19. Rašić-Milutinović Z., Peruničić- Peković G., Plješa S., Gluvić Z., Ilić M., Stokić E. (2007a): Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern. Med. 46, 945-951
20. Rašić-Milutinović Z., Peruničić- Peković G., Plješa S., Gluvi? Z., Sobajić S., Djurić I., Ristić D. (2007b): Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren. Fail. 29, 321-329
21. Rašić-Milutinović Z., Peruničić- Peković G., Plješa S., Čavala A., Gluvić Z., Bokan Lj., Stanković S. (2008): The effect of recombinant human erythropoietin treatment on insulin resistance and inflammatory markers in non-diabetic patients on maintenance hemodialysis. Hippokratia 12, 157-161
22. Siew E. D., Pupim L. B., Majchrzak K. M., Shintani A., Flakoll P. J., Ikizler T. A. (2007): Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int. 71, 146-152 Song Y. H., Li Y., Du J., Mitch W. E., Rosenthal N., Delafontaine P. (2005): Muscle-specific expression of insulin-like growth factor-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451-458
23. Stenvinkel P., Heimburger O., Paultre F., Diczfalusy U., Wang T., Berglund L., Jogestrand T. (1999): Strong association between malnutrition, inflammation and atherosclerosis in chronic kidney failure. Kidney Int. 55, 1899-1911
24. Toffolo G., Albright R., Joyner M., Dietz N., Cobelli C., Nair K. S. (2003): Model to assess muscle protein turnover: domain of validity using amino acyl-tRNA vs. surrogate measures of precursor pool. Am. J. Physiol., Endocrinol. Metab. 285, E1142-1149
25. Wang X., Hu Z., Hu J., Du J., Mitch W. E. (2006): Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147, 4160-4165